Beta Lactams Flashcards
Narrow Spectrum, penicillinase-susceptible penicillins
Penicillin G, Penicillin V
Narrow spectrum penicillin resistant organisms
- Most Staph aureus strains
- Many Neisseria gonorrhoeae strains
Very narrow spectrum (anti-staphylococcal), penicillinase-resistant penicillins
Methicillin
Oxacillin
Nafcillin
Very narrow spectrum penicillin resistant organisms
MRSA
PRSP
Wider spectrum, penicillinase-susceptible penicillins
Piperacilin Ampicillin Ticarcillin Amoxicillin (fat pata) -use with beta-lactamase inhibitors -synergistic w/ aminoglycosides
Enterococcal & listerial infection treatments
Ampicillin/aminoglycosides
PCN + Beta-lactamase inhibitors
Amox + Clavulanic acid (Augmentin)
Ampi + Sulbactam (Unasyn)
Piper+ Tazobactam (Zosyn)
Ticar + Clavulanic acid (Timentin)
AC, AS, PT, TC
PCN mechanisms of resistance
1) Beta lactamase (staph, gram-)
2) PBP modification (MRSA, MRSE, PRSP, eterococci)
3) Changes in Porin (gram-…P. aeruginosa)
4) Efflux pump (salmonella typhimurium)
Cephalosporin mechanisms of resistance
1) beta lactamases (less susceptible to staph penicillnases than PCN)
2) PBP modification (MRSA, PRSP)
3) Decrease in drug permeability
1st Generation Cephalosporins
Cefazolin
Cephalexin
Cefadroxil
2nd Generation Cephalosporins
Cefaclor Cefotetan Cefamandole Cefoxitin Cefuroximea Cefuroxime Axetil Cefproxil Loracarbef
3rd Generation Cephalosporins
Cefotaxime Cefixime Cefoperazone Ceftriaxone Ceftazidime Cefpodoxime Cefdinir
4th Generation Cephalosporin
Cefepime
Gram + and Gram - coverage
Patterns of cephalosporins from 1st to 3rd generations
- Decrease Gram+ coverage
- Increase Gram - coverage
- Increase CNS penetration
- Increase resistance to B-lactamase
Monobactam
Aztreonam
Monobactam coverage
- certain Gram - rods (resistant to B-lactamases produced by rods) including Pseudomonas
- NO activity against gram + or anaerobes
- Synergistic w/ aminoglycosides
Carbapenems
Imipenem
Meropenem
Ertapenem
Doripenem
Carbapenem coverage
-Broadest spectrum of all antibiotics!
> G+ cocci (staph/strep), G- rods (pseudomonas), anaerobes
> resistant to most B-lactamases, but susceptible to METALLO-B-LACTAMASE
-No coverage against:
MRSA, Listeria Monocytogenes, some enterococci, few hospital-strain Gram-
-Ertapenem: low Pseudomonas activity!
B-lactamase Inhibitors
Clavulanic acid (w/ Amox & Ticar)
Sulbactam (w/ Ampi)
Tazobactam (w/ Pipera)
MRSA & PRSP Treatment
Vancomycin: no B-lactam ring, no binding to PBP
|»_space;PRSP: Vanco + 3G Ceph
Vancomycin coverage
- Active against Gram (+)…MRSR, PRSP
- No coverage against Gram (-), can’t penetrate cell membrane
PCN, Cephalosporin Mechanism of Action
- Bind to PBP b/c they are D-Ala-D-Ala analogs
- Inhibit transpeptidase (comp. inhibitor)–> inhibit cell wall synth
- Activate autolysins (bac enzyme that cause lesions in cell memb and wall)
Monobactam, Carbapenem Mechanism of Action
-Binds to PBP (PBP3 for monobactam)
Vancomycin Mechanism of Action
- Binds to D-Ala-D-Ala terminus of nascent peptidoglycan pentapeptide
- Inhibits transglycosylase, sterically hinders ELONGATION of peptido & cross-linking
- Damages cytoplasmic memb
- CIDAL for dividing orgs
- can’t penetrate complex Gram - cell walls
Vancomycin Mechanism of Resistance
- D-Ala-D-Ala modification (VRE, VRSA)
- Change in drug permeability
Daptomycin coverage
VRE
VRSA
>CIDAL for Gram+….act on cell memb
> INACTIVE against Gram -
Daptomycin considerations
-Renal elimination >monitor Creatine phosphokinase activity to watch out for myopathy, esp w/ statins -Long 1/2 life (9hrs) -->once a day -predominantly cleared by kidney -long post-antibiotic effect -concentration-dependent killing